AmerisourceBergen Corporation with ticker code (ABC) now have 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 213 and 172 suggesting an average Analsyt target price of $189.93. Given that the stocks previous close was at $192.43 this would indicate that there is a downside of -1.3%. The 50 day moving average now sits at $175.24 and the 200 moving average now moves to $161.83. The market cap for the company is 38.62B. The stock price for the company is currently 190.92 USD
The potential market cap would be $38,113,610,156 based on the market consensus.
The company has a dividend yield of 1.09%. Other points of data to note are a P/E ratio of 24.6, revenue per share of 1203.91 and a 2.76% return on assets.
AmerisourceBergen Corporation is a global pharmaceutical sourcing and distribution services company. The Company’s U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The Company also focuses on specialty services and a global platform of pharma manufacturer services capabilities.
